FDI earnings for pharmaceutical and biological products Singapore 2013-2022
In 2022, the earnings of foreign direct investment (FDI) for pharmaceutical and biological products in Singapore amounted to approximately seven billion Singapore dollars, an increase compared to the previous year. Singapore is a leading center of biomedical sciences in Asia. The government of Singapore launched the Biomedical Sciences (BMS) initiative in 2000 that has since amplified the pharmaceutical industry in the country.